Dexcom (DXCM) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.52% |
| Dec 31, 2025 | 17.18% |
| Sep 30, 2025 | 36.22% |
| Jun 30, 2025 | 39.16% |
| Mar 31, 2025 | 47.10% |
| Dec 31, 2024 | 17.51% |
| Sep 30, 2024 | 31.10% |
| Jun 30, 2024 | 85.89% |
| Mar 31, 2024 | 47.50% |
| Dec 31, 2023 | 27.67% |
| Sep 30, 2023 | 39.94% |
| Jun 30, 2023 | 40.02% |
| Mar 31, 2023 | 36.20% |
| Dec 31, 2022 | 72.98% |
| Sep 30, 2022 | 127.16% |
| Jun 30, 2022 | 48.53% |
| Mar 31, 2022 | 23.70% |
| Dec 31, 2021 | 23.85% |
| Sep 30, 2021 | 51.65% |
| Jun 30, 2021 | 46.86% |
| Mar 31, 2021 | 32.93% |
| Dec 31, 2020 | 149.34% |
| Sep 30, 2020 | 30.38% |
| Jun 30, 2020 | 70.68% |
| Mar 31, 2020 | 30.16% |
| Dec 31, 2019 | 132.10% |
| Sep 30, 2019 | 60.97% |
| Jun 30, 2019 | -9.16% |
| Mar 31, 2019 | -16.30% |
| Dec 31, 2018 | -132.57% |
| Sep 30, 2018 | 56.76% |
| Jun 30, 2018 | 37.59% |
| Mar 31, 2018 | -16.67% |
| Dec 31, 2017 | 24.67% |
| Sep 30, 2017 | 32.08% |
| Jun 30, 2017 | 0.41% |
| Mar 31, 2017 | -21.22% |
| Dec 31, 2016 | 10.52% |
| Sep 30, 2016 | -6.97% |
| Jun 30, 2016 | -22.23% |
| Mar 31, 2016 | -10.13% |
| Dec 31, 2015 | 16.68% |
| Sep 30, 2015 | -26.57% |
| Jun 30, 2015 | 20.21% |